LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2020

Apr 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2020-04-22

Reporting Person: Santini Alexander A (EVP and CCO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-22	Common Stock	A	19893	—	Acquired	62397	Direct
2020-04-22	Common Stock	F	6813	$1.96	Disposed	55584	Direct

Footnotes

F1: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals.

F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.